Source: Owler

Global Blood Therapeutics, Inc.: GBT's revenue changed from $210.87M in Mar 2022 to $234.86M in Jun 2022

GBT’s Trailing Twelve Months revenue changed from $210.87M in Mar 2022 to $234.86M in Jun 2022 increasing 11.4% in this time period.

Read full article »
Global Blood Therapeutics, Inc.'s Competitors | Global Blood Therapeutics, Inc.'s News | Global Blood Therapeutics, Inc.'s Financials
Stay up-to-date with the latest news on GBT
Annual Revenue
$100-500M
Employees
250-500
Ted W. Love's photo - President & CEO of GBT

President & CEO

Ted W. Love

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on GBT